← SynDRA
METIPRANOLOL
SynDRA canonical compound SYN0005087 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ADRB1 | ADRB2 |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- ADRB1 ANTAGONIST
- Beta-1 adrenergic receptor antagonist
- ADRB2 ANTAGONIST
- Beta-2 adrenergic receptor antagonist
- adrenergic receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ACHE
- KCNH2
- TBXA2R
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- HTR2B
- ADORA3
- HTR1A
- HRH3
- HDAC6
- F2
- DRD3
- DRD1
- CHRM2
- CHRM1
- AR
- ADRA2A
- ADRA1A
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic beta-Antagonists
- beta-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympatholytics
ATC classes
- S01E · ANTIGLAUCOMA PREPARATIONS AND MIOTICS
- BETA BLOCKING AGENTS AND THIAZIDES
Cross-references
Synonyms
- OPTIPRANOLOL
- metipranolol hydrochloride
- DL-Metipranolol
- methypranol
- trimepranol
- metipranolol HCl
- D,l-metipranolol
- BM-01.004
- BM-01004
- BM01.004
- VUAB-6453
- VUAB6453
- VUAB6453 (SPOFA)
- Glauline
- Disorat
- Methypranol
- Metipranololum
- Trimepranol
- Turoptin
- Betanol (TN)
- Disorat (TN)
- Metipranololum [INN-Latin]
- OptiPranolol (TN)
- Trimepranol (TN)
- VUFB-6453
- Metipranolol (USAN/INN)
- Metipranolol [USAN:BAN:INN]
- 62164P
- X39AL81KEB
- (+-)-metipranolol
- CHEBI:6897
- DTXCID2026078
- metipranololo
- RefChem:925824
- S01ED04
- NCGC00159498-02
- EINECS 245-151-5
Look up METIPRANOLOL in the interactive SynDRA portal →